Overview

Study of BMS-587101 in Patients With Moderate to Severe Psoriasis

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn if BMS-587101 is effective on the treatment of Moderate to Severe Psoriasis. The safety of this treatment will also be studied.
Phase:
Phase 2
Details
Lead Sponsor:
Bristol-Myers Squibb